SCHEMBL31201366

SCHEMBL31201366

CCC(CC)Nc1cc(Nc2ccncn2)c2nnc(C3CC3)n2n1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CCNA2 P20248 2/20 0.35
▸ CDK2 P24941 2/20 0.35
▸ CCNA1 P78396 2/20 0.35
▸ CDK5 Q00535 2/20 0.35
▸ DYRK1A Q13627 2/20 0.35
▸ CDK5R1 Q15078 2/20 0.35
▸ MALT1 Q9UDY8 2/20 0.33
▸ MKNK2 Q9HBH9 5/20 0.33
▸ MKNK1 Q9BUB5 4/20 0.32
▸ GABRA1 P14867 3/20 0.32
▸ GABRG2 P18507 3/20 0.32
▸ GABRB3 P28472 3/20 0.32
▸ GABRA5 P31644 3/20 0.32
▸ GABRA3 P34903 3/20 0.32
▸ GABRA2 P47869 3/20 0.32
▸ IRAK4 Q9NWZ3 1/20 0.32
▸ TYK2 P29597 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31201329 0.88 BRD4 (0.33) CCNA2CDK2CCNA1CDK5DYRK1A
SCHEMBL31201351 0.87 GABRG2 (0.41) CCNA2CDK2CCNA1CDK5DYRK1A
SCHEMBL31201371 0.85 PDE10A (0.33) CCNA2CDK2CDK5DYRK1ACDK5R1
SCHEMBL31201167 0.84 GABRA1 (0.36) CCNA2CDK2CCNA1CDK5DYRK1A
SCHEMBL31201155 0.83 GABRA1 (0.33) CCNA2CDK2CDK5DYRK1ACDK5R1
SCHEMBL31201308 0.83 PDE10A (0.31) CCNA2CDK2CCNA1CDK5DYRK1A
SCHEMBL31201240 0.83 CCNA2 (0.39) CCNA2CDK2CCNA1CDK5DYRK1A
SCHEMBL31201482 0.82 GABRA1 (0.34) CCNA2CDK2CDK5DYRK1ACDK5R1
SCHEMBL31201340 0.82 CCNA2 (0.39) CCNA2CDK2CCNA1CDK5DYRK1A
SCHEMBL31201527 0.80 MALT1 (0.42) CCNA2CDK2CCNA1MALT1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP claimed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO claimed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP claimed
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP disclosed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO disclosed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP disclosed
Send feedback